Dosidal · Switzerland

Gaviscon Liquid Mint, Suspension zum Einnehmen im Beutel

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:62887 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 62887
atc: A02AX
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2013-06-05
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A02AX
authorisation_number: 62887
form: SUORB
holder: Reckitt Benckiser (Switzerland) AG
holder_partner_nr: 1002083
it_number: 04.01.0.
name: Gaviscon Liquid Mint, Suspension zum Einnehmen im Beutel
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
xyTc6sCIVaZhKIXuhHEi5GC8RPVH58ZNT6R84kmb4a6tiycNc8XqH3Ge4pB8jUZFJxOOfFtjdkNYobUY1rhkHA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:62887 · Related records in other markets · Dosidal